VALN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Valneva and Pfizer demonstrated strong Phase 3 efficacy of their Lyme disease vaccine candidate in the VALOR trialMar 23, 2026
- Valneva announced positive final Phase 2 results for Lyme disease vaccine candidateNov 26, 2025
- Valneva reports positive results for Phase 1 trial of second-generation Zika vaccine candidateNov 4, 2025
- Valneva reports 95% seroresponse four years after single shot of chikungunya vaccine IXCHIQ®Sep 30, 2025
- Valneva reports further positive Phase 2 safety and immunogenicity results for Lyme disease vaccine candidateSep 3, 2025